More importantly, CRC patients with advanced TNM stage (III and IV) exhibited decreased CTNNAP1 expression than those with low TNM stage (I and II) (P<0.05; Figure 1C). This evidence concerns the gene CTNNA1P1 and colorectal carcinoma.